中康控股2022 中期报告

(Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立的有限公司) Stock Code 股份代號: 2361 中康控股有限公司Sinohealth Holdings Limited2022 INTERIM REPORT 中期報告2022 INTERIM REPORT 中期報告Sinohealth Holdings Limited 中康控股有限公司 Contents目錄2Corporate Information公司資料6Business Overview and Outlook業務概覽及展望11Management Discussion and Analysis管理層討論及分析25Corporate Governance and Other Information企業管治及其他資料33Interim Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income中期簡明綜合損益及其他全面收益表34Interim Condensed Consolidated Statement of Financial Position中期簡明綜合財務狀況表36Interim Condensed Consolidated Statement of Changes in Equity中期簡明綜合權益變動表38Interim Condensed Consolidated Statement of Cash Flows中期簡明綜合現金流量表41Notes to the Interim Condensed Consolidated Financial Information中期簡明綜合財務資料附註65Definitions釋義 Sinohealth Holdings Limited 中康控股有限公司Interim Report 2022 二零二二年中期報告2Corporate Information公司資料董事會執行董事吳鬱抒先生（主席）王莉芳女士非執行董事付海濤先生獨立非執行董事王丹舟女士杜依琳女士魏斌先生審核委員會魏斌先生（主席）王丹舟女士杜依琳女士薪酬委員會王丹舟女士（主席）杜依琳女士王莉芳女士提名委員會吳鬱抒先生（主席）杜依琳女士王丹舟女士授權代表吳鬱抒先生張瀟女士聯席公司秘書易旭暉女士張瀟女士ACG, HKACGBOARD OF DIRECTORSExecutive DirectorsMr. Wu Yushu (Chairman)Ms. Wang LifangNon-executive DirectorMr. Fu HaitaoIndependent Non-executive DirectorsMs. Wang DanzhouMs. Du YilinMr. Wei BinAUDIT COMMITTEEMr. Wei Bin (Chairman)Ms. Wang DanzhouMs. Du YilinREMUNERATION COMMITTEEMs. Wang Danzhou (Chairman)Ms. Wang LifangMs. Du YilinNOMINATION COMMITTEEMr. Wu Yushu (Chairman)Ms. Wang DanzhouMs. Du YilinAUTHORISED REPRESENTATIVESMr. Wu YushuMs. Zhang XiaoJOINT COMPANY SECRETARIESMs. Yi XuhuiMs. Zhang Xiao ACG, HKACG Sinohealth Holdings Limited 中康控股有限公司Interim Report 2022 二零二二年中期報告3Corporate Information公司資料開曼群島註冊辦事處89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands中國主要營業地點中國廣東省廣州市南沙區黃閣鎮望江二街5號1111房香港主要營業地點香港灣仔皇后大道東248號大新金融中心40樓開曼群島股份過戶登記總處Ogier Global (Cayman) Limited89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands香港證券登記處寶德隆證券登記有限公司香港北角電氣道148號21樓2103B室合規顧問智富融資有限公司香港中環雲咸街8號3樓REGISTERED OFFICE IN THE CAYMAN ISLANDS89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman IslandsPRINCIPAL PLACE OF BUSINESS IN THE PRCRoom 1111, No. 5 Wangjiang Second StreetHuangge Town, Nansha DistrictGuangzhou CityGuangdong ProvincePRCPRINCIPAL PLACE OF BUSINESS IN HONG KONG40/F, Dah Sing Financial CentreNo. 248 Queen’s Road EastWanchaiHong KongCAYMAN ISLANDS PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICEOgier Global (Cayman) Limited89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman IslandsHONG KONG SHARE REGISTRAR AND TRANSFER OFFICEBoardroom Share Registrars (HK) Limited2103B, 21/F148 Electric RoadNorth PointHong KongCOMPLIANCE ADVISERGiraffe Capital Limited3/F, 8 Wyndham StreetCentralHong Kong Sinohealth Holdings Limited 中康控股有限公司Interim Report 2022 二零二二年中期報告4Corporate Information公司資料法律顧問關於香港法例競天公誠律師事務所有限法律責任合夥香港皇后大道中15號置地廣場公爵大廈32樓3203-3207室關於中國法律競天公誠律師事務所中國上海市淮海中路1010號嘉華中心45層核數師安永會計師事務所執業會計師註冊公眾利益實體核數師香港鰂魚涌英皇道979號太古坊1座27樓LEGAL ADVISERSAs to Hong Kong lawJingtian & Gongcheng LLPSuites 3203-320732/F, Edinburgh TowerThe Landmark15 Queen’s Road CentralHong KongAs to PRC lawJingtian & Gongcheng45/F, K. Wah Centre1010 Huaihai Road (M)ShanghaiChinaAUDITORErnst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong Sinohealth Holdings Limited 中康控股有限公司Interim Report 2022 二零二二年中期報告5Corporate Information公司資料主要往來銀行平安銀行廣州黃埔大道支行中國廣東省廣州市天河區黃埔大道西76號富力盈隆廣場首層中國光大銀行廣州黃埔大道西支行中國廣東省廣州市天河區黃埔大道118號勤建大廈首層02商舖股份代號2361公司網址ir.sinohealth.cnPRINCIPAL BANKSPing An Bank Guangzhou Huangpu Avenue Branch1/F, Fulilong SquareNo. 76 Huangpu Avenue WestTianhe DistrictGuangzhou CityGuangdong ProvincePRCChina Everbright Bank Guangzhou Huangpu Avenue West BranchSuit 02, 1/F, Qinjian MansionNo. 118 Huangpu AvenueTianhe DistrictGuangzhou CityGuangdong ProvincePRCSTOCK CODE2361COMPANY’S WEBSITEir.sinohealth.cn Sinohealth Holdings Limited 中康控股有限公司Interim Report 2022 二零二二年中期報告6Business Overview and Outlook業務概覽及展望In the past fifteen years, the Group has successfully grown into the largest healthcare insight solution provider for the medical products and channels segment in China. Leveraging on its strong research and development capabilities in big data, cloud computing and AI technology and partnering with over 60,000 retail pharmacy stores nationwide, the Group has built a large healthcare data middleware in China, “Tiangong No.1”, storing over 25TB data entries. The Group has established extensive industry networks, hosting three important annual industrial events, namely Industry Prospect Event, Merchandise Trading Event and Retail Sales Event to connect the industry. The Group has achieved a leading position in developing digital business in the healthcare sector through its data technology and governance, rich database and industry networks.Leveraging on its competitive strengths, the Group provides customised or standardised digital intelligence solu